Contribution of bone imaging in the pharmacoepidemiology of fractures

• In: Osteoporosis And Fractures (SIGs Nuclear/Radiologic Pharmacy and Pharmacoeconomics/Pharmacoepidemiology) on Wednesday, 8 September 2004, 9:00-12:00
• At: New Orleans (USA) (2004)
• Type: Presentation
• By: STAA, Tjeerd (Procter&Gamble Pharmaceuticals, Epidemiology, Egham, United Kingdom)
• Abstract:

  To date, assessment of bone mineral density (BMD) has been important in the diagnosis of osteoporosis and the WHO definition of osteoporosis is widely accepted as an intervention threshold in practice guidelines. A meta-analysis has reported that hip fracture prediction with BMD alone is at least as good as blood pressure readings to predict

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login